Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • fazulur.r
    Junior Member
    • Oct 2013
    • 3

    #1

    FeatureCounts highest counts for unstranded option

    Dear All,

    I am working on RNASeq data which is generated using Truseq straded HT kit.

    I have done removing adapters and aligned reads using STAR 2 pass mode.

    And ran feature counts (subread 1.5.1) using -s option three times 0,1 and 2. More reads were mapped to features when I specified -s as "0". But rseqc infer it as reverse stranded.

    Here are the commands which I used:

    featureCounts -t exon -s 1 -T 12 -g gene_id -a genes.gtf -o featurecounts.txt sample.starAligned.sortedByCoord.out.bam

    sum of counts : 34133722

    featureCounts -t exon -s 2 -T 12 -g gene_id -a genes.gtf -o featurecounts.txt sample.starAligned.sortedByCoord.out.bam

    sum of counts : 34029447

    featureCounts -t exon -s 0 -T 12 -g gene_id -a genes.gtf -o featurecounts.txt sample.starAligned.sortedByCoord.out.bam

    sum of counts : 63157326

    Am I using parameters correctly? And summing up counts on 7th column of featurecounts output.Is this right way to predict strand?

    Few observations:

    I observed %GC (49 - 55%) and few overrepresented sequences which are showing as "no hit" in fastqc output. Out of 95% properly paired only 70% were showing as "uniquely mapped" and 20-30% were multimapped.

    Out of that, Only 20-30% mapped reads were assigned to featureCounts in "-s 2" mode (reverse).

    Since our data is from trueseq library. It should be reverse stranded.
    And we should not get high number of counts for both -s 1 and -s 2 options for strand specific data.

    Could you please suggest how can I resolve this issue.

    Thanks In Advance
    Fazulur Rehaman

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    Yesterday, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Today, 10:52 AM
0 responses
8 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 05:39 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Working...